A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

Cited by (1,095)

Items 101–200 of 1,095

1. Ketamine for Depression: Where Do We Go from Here?
   aan het Rot, Marije, Zarate, Carlos A., Charney, Dennis S., Mathew, Sanjay J. · 2012 · Biological Psychiatry
2. Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis
   Bahji, Anees, Vazquez, Gustavo H., Zarate, Carlos A. · 2021 · Journal of Affective Disorders
3. Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond
   Krystal, John H., Sanacora, Gerard, Duman, Ronald S. · 2013 · Biological Psychiatry
4. Brain-Derived Neurotrophic Factor Val66Met Allele Impairs Basal and Ketamine-Stimulated Synaptogenesis in Prefrontal Cortex
   Liu, Rong-Jian, Lee, Francis S., Li, Xiao-Yuan, Bambico, Francis, Duman, Ronald S., Aghajanian, George K. · 2012 · Biological Psychiatry
5. Neural basis of major depressive disorder: Beyond monoamine hypothesis
   Boku, Shuken, Nakagawa, Shin, Toda, Hiroyuki, Hishimoto, Akitoyo · 2018 · Psychiatry and Clinical Neurosciences
6. Global Brain Gene Expression Analysis Links Glutamatergic and GABAergic Alterations to Suicide and Major Depression
   Sequeira, Adolfo, Mamdani, Firoza, Ernst, Carl, Vawter, Marquis P., Bunney, William E., Lebel, Veronique, Rehal, Sonia, Klempan, Tim, Gratton, Alain, Benkelfat, Chawki et al. · 2009 · PLoS ONE
7. The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder
   Jernigan, Courtney S., Goswami, Dharmendra B., Austin, Mark C., Iyo, Abiye H., Chandran, Agata, Stockmeier, Craig A., Karolewicz, Beata · 2011 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
8. Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept
   Rodriguez, Carolyn I, Kegeles, Lawrence S, Levinson, Amanda, Feng, Tianshu, Marcus, Sue M, Vermes, Donna, Flood, Pamela, Simpson, Helen B · 2013 · Neuropsychopharmacology
9. Ketamine: 50 Years of Modulating the Mind
   Li, Linda, Vlisides, Phillip E. · 2016 · Frontiers in Human Neuroscience
10. Glutamate-based antidepressants: 20 years on
    Phil Skolnick, Piotr Popik, Ramón Trullás · 2009 · Trends in Pharmacological Sciences
11. Emerging role of glutamate in the pathophysiology of major depressive disorder
    Hashimoto, Kenji · 2009 · Brain Research Reviews
12. BDNF release is required for the behavioral actions of ketamine
    Lepack, A. E., Fuchikami, M., Dwyer, J. M., Banasr, M., Duman, R. S. · 2015 · International Journal of Neuropsychopharmacology
13. A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes
    McGirr, A., Berlim, M. T., Bond, D. J., Fleck, M. P., Yatham, L. N., Lam, R. W. · 2015 · Psychological Medicine
14. Consequences of chronic ketamine self‐administration upon neurocognitive function and psychological wellbeing: a 1‐year longitudinal study
    Morgan, Celia J. A., Muetzelfeldt, Leslie, Curran, H. Valerie · 2010 · Addiction
15. Prefrontal cortex circuits in depression and anxiety: contribution of discrete neuronal populations and target regions
    Hare, Brendan D., Duman, Ronald S. · 2020 · Molecular Psychiatry
16. Neurobiology of depression, fibromyalgia and neuropathic pain
    Vladimir Maletic · 2009 · Frontiers in bioscience
17. A neurotrophic hypothesis of depression: role of synaptogenesis in the actions of NMDA receptor antagonists
    Duman, Ronald S., Li, Nanxin · 2012 · Philosophical Transactions of the Royal Society B: Biological Sciences
18. High-Fat Diet Induced Anxiety and Anhedonia: Impact on Brain Homeostasis and Inflammation
    Dutheil, Sophie, Ota, Kristie T, Wohleb, Eric S, Rasmussen, Kurt, Duman, Ronald S · 2016 · Neuropsychopharmacology
19. Single-dose infusion ketamine and non-ketamine <i>N</i> -methyl- <scp>d</scp> -aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories
    Kishimoto, T., Chawla, J. M., Hagi, K., Zarate, C. A., Kane, J. M., Bauer, M., Correll, C. U. · 2016 · Psychological Medicine
20. GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine
    Miller, Oliver H, Yang, Lingling, Wang, Chih-Chieh, Hargroder, Elizabeth A, Zhang, Yihui, Delpire, Eric, Hall, Benjamin J · 2014 · eLife
21. Early environmental influences on the development of children's brain structure and function
    Miguel, Patrícia M, Pereira, Lenir O, Silveira, Patrícia P, Meaney, Michael J · 2019 · Developmental Medicine &amp; Child Neurology
22. Psychedelics reopen the social reward learning critical period
    Nardou, Romain, Sawyer, Edward, Song, Young Jun, Wilkinson, Makenzie, Padovan-Hernandez, Yasmin, de Deus, Júnia Lara, Wright, Noelle, Lama, Carine, Faltin, Sehr, Goff, Loyal A. et al. · 2023 · Nature
23. R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
    Zhang, Ji-chun, Li, Su-xia, Hashimoto, Kenji · 2014 · Pharmacology Biochemistry and Behavior
24. Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: A double-blind placebo controlled study
    Robert J. Schwartzman, Guillermo M. Alexander, John R. Grothusen, Terry Paylor, Erin Renée Reichenberger, Marielle J. Perreault · 2009 · Pain
25. Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial.
    von Rotz, Robin, Schindowski, Eva M., Jungwirth, Johannes, Schuldt, Anna, Rieser, Nathalie M., Zahoranszky, Katharina, Seifritz, Erich, Nowak, Albina, Nowak, Peter, Jäncke, Lutz et al. · 2023 · eClinicalMedicine
26. The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes
    Beumer, Wouter, Gibney, Sinead M, Drexhage, Roosmarijn C, Pont-Lezica, Lorena, Doorduin, Janine, Klein, Hans C, Steiner, Johann, Connor, Thomas J, Harkin, Andrew, Versnel, Marjan A et al. · 2012 · Journal of Leukocyte Biology
27. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression
    Koike, Hiroyuki, Iijima, Michihiko, Chaki, Shigeyuki · 2011 · Behavioural Brain Research
28. EFFECTS OF KETAMINE ON EXPLICIT AND IMPLICIT SUICIDAL COGNITION: A RANDOMIZED CONTROLLED TRIAL IN TREATMENT-RESISTANT DEPRESSION: Effects of ketamine on suicidality
    Price, Rebecca B., Iosifescu, Dan V., Murrough, James W., Chang, Lee C., Al Jurdi, Rayan K., Iqbal, Syed Z., Soleimani, Laili, Charney, Dennis S., Foulkes, Alexandra L., Mathew, Sanjay J. · 2014 · Depression and Anxiety
29. Ketamine administration in depressive disorders: a systematic review and meta-analysis
    Fond, Guillaume, Loundou, Anderson, Rabu, Corentin, Macgregor, Alexandra, Lançon, Christophe, Brittner, Marie, Micoulaud-Franchi, Jean-Arthur, Richieri, Raphaelle, Courtet, Philippe, Abbar, Mocrane et al. · 2014 · Psychopharmacology
30. Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
    Hashimoto, Kenji · 2019 · Psychiatry and Clinical Neurosciences
31. Overview of glutamatergic neurotransmission in the nervous system
    Mark J. Niciu, Benjamin Kelmendi, Gerard Sanacora · 2011 · Pharmacology Biochemistry and Behavior
32. Serotonin 5-HT1A Receptors as Targets for Agents to Treat Psychiatric Disorders: Rationale and Current Status of Research
    Celada, Pau, Bortolozzi, Analía, Artigas, Francesc · 2013 · CNS Drugs
33. Role of BDNF in the Pathophysiology and Treatment of Depression: Activity-Dependent Effects Distinguish Rapid-Acting Antidepressants
    Duman, Ronald S., Deyama, Satoshi, Fogaça, Manoela Viar · 2021 · European Journal of Neuroscience
34. Blinding and expectancy confounds in psychedelic randomized controlled trials
    Muthukumaraswamy, Suresh D., Forsyth, Anna, Lumley, Thomas · 2021 · Expert Review of Clinical Pharmacology
35. Serotonin receptors involved in antidepressant effects
    Artigas, Francesc · 2013 · Pharmacology &amp; Therapeutics
36. Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study
    Ibrahim, Lobna, DiazGranados, Nancy, Franco-Chaves, Jose, Brutsche, Nancy, Henter, Ioline D, Kronstein, Phillip, Moaddel, Ruin, Wainer, Irving, Luckenbaugh, David A, Manji, Husseini K et al. · 2012 · Neuropsychopharmacology
37. Cognitive dysfunction in depression: Neurocircuitry and new therapeutic strategies
    Murrough, James W., Iacoviello, Brian, Neumeister, Alexander, Charney, Dennis S., Iosifescu, Dan V. · 2011 · Neurobiology of Learning and Memory
38. Affective neuroscience of the emotional BrainMind: evolutionary perspectives and implications for understanding depression
    Jaak Panksepp · 2010 · Dialogues in Clinical Neuroscience
39. A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality
    Bay-Richter, Cecilie, Linderholm, Klas R., Lim, Chai K., Samuelsson, Martin, Träskman-Bendz, Lil, Guillemin, Gilles J., Erhardt, Sophie, Brundin, Lena · 2015 · Brain, Behavior, and Immunity
40. The paradoxical psychological effects of lysergic acid diethylamide LSD
    Carhart-Harris, R. L., Kaelen, M., Bolstridge, M., Williams, T. M., Williams, L. T., Underwood, R., Feilding, A., Nutt, D. J. · 2016 · Psychological Medicine
41. Ketamine Treatment and Global Brain Connectivity in Major Depression
    Abdallah, Chadi G, Averill, Lynnette A, Collins, Katherine A, Geha, Paul, Schwartz, Jaclyn, Averill, Christopher, DeWilde, Kaitlin E, Wong, Edmund, Anticevic, Alan, Tang, Cheuk Y et al. · 2017 · Neuropsychopharmacology
42. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial
    Murrough, J. W., Soleimani, L., DeWilde, K. E., Collins, K. A., Lapidus, K. A., Iacoviello, B. M., Lener, M., Kautz, M., Kim, J., Stern, J. B. et al. · 2015 · Psychological Medicine
43. Depression and epilepsy: Epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence
    Andres Miguel Kanner, Steven C. Schachter, John J. Barry, Dale C. Hersdorffer, Marco Mula, Michael Trimble, Bruce P. Hermann, Alan E. Ettinger, David Dunn, Rochelle Caplan et al. · 2012 · Epilepsy & Behavior
44. Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial
    Sanjay J. Mathew, James W. Murrough, Marije aan het Rot, Katherine Anne Collins, David L. Reich, Dennis S. Charney · 2009 · The International Journal of Neuropsychopharmacology
45. Inflammation, Glutamate, and Glia in Depression:<i>A Literature Review</i>
    McNally, Leah, Bhagwagar, Zubin, Hannestad, Jonas · 2008 · CNS Spectrums
46. Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice
    Beurel, E, Song, L, Jope, R S · 2011 · Molecular Psychiatry
47. Ketamine Decreases Resting State Functional Network Connectivity in Healthy Subjects: Implications for Antidepressant Drug Action
    Scheidegger, Milan, Walter, Martin, Lehmann, Mick, Metzger, Coraline, Grimm, Simone, Boeker, Heinz, Boesiger, Peter, Henning, Anke, Seifritz, Erich · 2012 · PLoS ONE
48. Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety
    Ballard, Elizabeth D., Ionescu, Dawn F., Vande Voort, Jennifer L., Niciu, Mark J., Richards, Erica M., Luckenbaugh, David A., Brutsché, Nancy E., Ameli, Rezvan, Furey, Maura L., Zarate, Carlos A. · 2014 · Journal of Psychiatric Research
49. Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
    Browne, Caroline A., Lucki, Irwin · 2013 · Frontiers in Pharmacology
50. GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects
    Burgdorf, Jeffrey, Zhang, Xiao-lei, Nicholson, Katherine L, Balster, Robert L, David Leander, J, Stanton, Patric K, Gross, Amanda L, Kroes, Roger A, Moskal, Joseph R · 2013 · Neuropsychopharmacology
51. Neuronal plasticity and neurotrophic factors in drug responses
    Castrén, E, Antila, H · 2017 · Molecular Psychiatry
52. Neuroplasticity Underlying the Comorbidity of Pain and Depression
    Lisa Doan, Toby R. Manders, Jing Wang · 2015 · Neural Plasticity
53. Do the dissociative side effects of ketamine mediate its antidepressant effects?
    Luckenbaugh, David A., Niciu, Mark J., Ionescu, Dawn F., Nolan, Neal M., Richards, Erica M., Brutsche, Nancy E., Guevara, Sara, Zarate, Carlos A. · 2014 · Journal of Affective Disorders
54. Acute suppression of spontaneous neurotransmission drives synaptic potentiation
    Nosyreva, Elena, Szabla, Kristen, Autry, Anita E., Ryazanov, Alexey G., Monteggia, Lisa M., Kavalali, Ege T. · 2013 · The Journal of Neuroscience
55. Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression
    Zarate, Carlos A., Brutsche, Nancy, Laje, Gonzalo, Luckenbaugh, David A., Venkata, Swarajya L. Vattem, Ramamoorthy, Anuradha, Moaddel, Ruin, Wainer, Irving W. · 2012 · Biological Psychiatry
56. Neurological diseases and pain
    David Borsook · 2011 · Brain
57. Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review
    Molero, P., Ramos-Quiroga, J. A., Martin-Santos, R., Calvo-Sánchez, E., Gutiérrez-Rojas, L., Meana, J. J. · 2018 · CNS Drugs
58. The use of ketamine as an antidepressant: a systematic review and meta‐analysis
    Coyle, Caoimhe M., Laws, Keith R. · 2015 · Human Psychopharmacology: Clinical and Experimental
59. HCN1 Channel Subunits Are a Molecular Substrate for Hypnotic Actions of Ketamine
    Xiangdong Chen, Shaofang Shu, Douglas A. Bayliss · 2009 · Journal of Neuroscience
60. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
    Amit Anand, Sanjay J. Mathew, Gerard Sanacora, James W. Murrough, Fernando S. Goes, Murat I. Altinay, Amy Starr Aloysi, Ali Abbas Asghar‐Ali, Brian Scott Barnett, Lee C. Chang et al. · 2023 · New England Journal of Medicine
61. Reduced Metabotropic Glutamate Receptor 5 Density in Major Depression Determined by [¹¹C]ABP688 PET and Postmortem Study
    Deschwanden, Alexandra, Karolewicz, Beata, Feyissa, Anteneh M., Treyer, Valerie, Ametamey, Simon M., Johayem, Anass, Burger, Cyrill, Auberson, Yves P., Sovago, Judit, Stockmeier, Craig A. et al. · 2011 · American Journal of Psychiatry
62. Increased Anterior Cingulate Cortical Activity in Response to Fearful Faces: A Neurophysiological Biomarker that Predicts Rapid Antidepressant Response to Ketamine
    Salvadore, Giacomo, Cornwell, Brian R., Colon-Rosario, Veronica, Coppola, Richard, Grillon, Christian, Zarate, Carlos A., Manji, Husseini K. · 2009 · Biological Psychiatry
63. Glutamatergic and resting state functional connectivity correlates of severity in major depression - the role of pregenual anterior cingulate cortex and anterior insula
    Horn · 2010 · Frontiers in Systems Neuroscience
64. Ketamine and the next generation of antidepressants with a rapid onset of action
    Rodrigo Machado‐Vieira, Giacomo Salvadore, Nancy Diazgranados, Carlos A. Zarate · 2009 · Pharmacology & Therapeutics
65. The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor
    Benjamin Adam Samuels, Katherine M. Nautiyal, Andrew C. Kruegel, Marjorie R. Levinstein, Valerie M. Magalong, Madalee M. Gassaway, Steven G. Grinnell, Jaena Han, Michael A. Ansonoff, John E. Pintar et al. · 2017 · Neuropsychopharmacology
66. BDNF in sleep, insomnia, and sleep deprivation
    Karen Schmitt, Edith Holsboer‐Trachsler, Anne Eckert · 2016 · Annals of Medicine
67. Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression
    Lally, N, Nugent, A C, Luckenbaugh, D A, Ameli, R, Roiser, J P, Zarate, C A · 2014 · Translational Psychiatry
68. Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics.
    de Vos, Cato M. H., Mason, Natasha L., Kuypers, Kim P. C. · 2021 · Frontiers in Psychiatry
69. The Role of Memantine in the Treatment of Psychiatric Disorders Other Than the Dementias: A Review of Current Preclinical and Clinical Evidence
    Sani, Gabriele, Serra, Giulia, Kotzalidis, Giorgio D., Romano, Silvia, Tamorri, Stefano M., Manfredi, Giovanni, Caloro, Matteo, Telesforo, C. Ludovica, Caltagirone, Saverio S., Panaccione, Isabella et al. · 2012 · CNS Drugs
70. Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability
    Bonaventura, Jordi, Lam, Sherry, Carlton, Meghan, Boehm, Matthew A., Gomez, Juan L., Solís, Oscar, Sánchez-Soto, Marta, Morris, Patrick J., Fredriksson, Ida, Thomas, Craig J. et al. · 2021 · Molecular Psychiatry
71. Amino Acid Neurotransmitters Assessed by Proton Magnetic Resonance Spectroscopy: Relationship to Treatment Resistance in Major Depressive Disorder
    Price, Rebecca B., Shungu, Dikoma C., Mao, Xiangling, Nestadt, Paul, Kelly, Chris, Collins, Katherine A., Murrough, James W., Charney, Dennis S., Mathew, Sanjay J. · 2009 · Biological Psychiatry
72. Spine synapse remodeling in the pathophysiology and treatment of depression
    Duman, Catharine H., Duman, Ronald S. · 2015 · Neuroscience Letters
73. Scopolamine Rapidly Increases Mammalian Target of Rapamycin Complex 1 Signaling, Synaptogenesis, and Antidepressant Behavioral Responses
    Voleti, Bhavya, Navarria, Andrea, Liu, Rong-Jian, Banasr, Mounira, Li, Nanxin, Terwilliger, Rose, Sanacora, Gerard, Eid, Tore, Aghajanian, George, Duman, Ronald S. · 2013 · Biological Psychiatry
74. Deep brain stimulation for treatment-resistant depression: an integrative review of preclinical and clinical findings and translational implications
    Manoj P. Dandekar, Albert J. Fenoy, Andre Ferrer Carvalho, Jair C. Soares, João Quevedo · 2018 · Molecular Psychiatry
75. An excitatory synapse hypothesis of depression
    Thompson, Scott M., Kallarackal, Angy J., Kvarta, Mark D., Van Dyke, Adam M., LeGates, Tara A., Cai, Xiang · 2015 · Trends in Neurosciences
76. Optogenetic stimulation of infralimbic PFC reproduces ketamine’s rapid and sustained antidepressant actions
    Fuchikami, Manabu, Thomas, Alexandra, Liu, Rongjian, Wohleb, Eric S., Land, Benjamin B., DiLeone, Ralph J., Aghajanian, George K., Duman, Ronald S. · 2015 · Proceedings of the National Academy of Sciences
77. MR Spectroscopic Studies of the Brain in Psychiatric Disorders
    Richard J. Maddock, Michael H. Buonocore · 2011 · Current topics in behavioral neurosciences
78. The timing of antidepressant effects: a comparison of diverse pharmacological and somatic treatments
    Machado-Vieira, Rodrigo, Baumann, Jacqueline, Wheeler-Castillo, Cristina, Latov, David, Henter, Ioline D., Salvadore, Giacomo, Zarate, Carlos A. · 2010 · Pharmaceuticals
79. Ketamine and rapid antidepressant action: New treatments and novel synaptic signaling mechanisms
    Krystal, John H., Kavalali, Ege T., Monteggia, Lisa M. · 2024 · Neuropsychopharmacology
80. Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine
    Danilo De Gregorio, Argel Aguilar‐Valles, Katrin H. Preller, Boris Dov Heifets, Meghan Hibicke, Jennifer Mitchell, Gabriella Gobbi · 2020 · Journal of Neuroscience
81. Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
    Tomislav Majić, Timo Torsten Schmidt, Jürgen Gallinat · 2015 · Journal of Psychopharmacology
82. Reviewing the Potential of Psychedelics for the Treatment of PTSD
    Krediet, Erwin, Bostoen, Tijmen, Breeksema, Joost, van Schagen, Annette, Passie, Torsten, Vermetten, Eric · 2020 · International Journal of Neuropsychopharmacology
83. Revolution Stalled
    Hyman, Steven E. · 2012 · Science Translational Medicine
84. Ketamine: NMDA Receptors and Beyond
    Zorumski, Charles F., Izumi, Yukitoshi, Mennerick, Steven · 2016 · The Journal of Neuroscience
85. Synaptic Mechanisms Underlying Rapid Antidepressant Action of Ketamine
    Kavalali, Ege T., Monteggia, Lisa M. · 2012 · American Journal of Psychiatry
86. Frequency-modulated 50 kHz ultrasonic vocalizations: a tool for uncovering the molecular substrates of positive affect
    Burgdorf, Jeffrey, Panksepp, Jaak, Moskal, Joseph R. · 2011 · Neuroscience &amp; Biobehavioral Reviews
87. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department
    Gregory Luke Larkin, Annette L. Beautrais · 2011 · The International Journal of Neuropsychopharmacology · Retracted
88. Placebo‐controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression
    Colleen K A Loo, Verònica Gálvez, Emily J O’Keefe, Philip Bowden Mitchell, D. Hadzi‐Pavlovic, John Leyden, S. Harper, Andrew Alexander Somogyi, Rosalyn Lai, Cynthia Shannon Weickert et al. · 2016 · Acta Psychiatrica Scandinavica
89. Serotonin and beyond: therapeutics for major depression
    Pierre Blier, Mostafa El Mansari · 2013 · Philosophical Transactions of the Royal Society B Biological Sciences
90. Ketamine as a Prophylactic Against Stress-Induced Depressive-like Behavior
    Rebecca A. Brachman, Josephine Cecelia McGowan, Jennifer N. Perusini, Sean C. Lim, Thu Ha Pham, Charlène Faye, Alain Michel Gardier, Indira Mendez‐David, Denis Joseph Paul David, René Hen et al. · 2015 · Biological Psychiatry
91. Intravenous arketamine for treatment-resistant depression: open-label pilot study
    Leal, Gustavo C., Bandeira, Igor D., Correia-Melo, Fernanda S., Telles, Manuela, Mello, Rodrigo P., Vieira, Flavia, Lima, Cassio S., Jesus-Nunes, Ana Paula, Guerreiro-Costa, Lívia N. F., Marback, Roberta F. et al. · 2021 · European Archives of Psychiatry and Clinical Neuroscience
92. GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine
    Liu, Rong-Jian, Fuchikami, Manabu, Dwyer, Jason M, Lepack, Ashley E, Duman, Ronald S, Aghajanian, George K · 2013 · Neuropsychopharmacology
93. Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder
    Duncan, Wallace C., Sarasso, Simone, Ferrarelli, Fabio, Selter, Jessica, Riedner, Brady A., Hejazi, Nadia S., Yuan, Peixiong, Brutsche, Nancy, Manji, Husseini K., Tononi, Giulio et al. · 2013 · International Journal of Neuropsychopharmacology
94. A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression
    Zarate, Carlos A., Mathews, Daniel, Ibrahim, Lobna, Chaves, Jose Franco, Marquardt, Craig, Ukoh, Immaculata, Jolkovsky, Libby, Brutsche, Nancy E., Smith, Mark A., Luckenbaugh, David A. · 2013 · Biological Psychiatry
95. Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression
    Haile, C. N., Murrough, J. W., Iosifescu, D. V., Chang, L. C., Al Jurdi, R. K., Foulkes, A., Iqbal, S., Mahoney, J. J., De La Garza, R., Charney, D. S. et al. · 2014 · The International Journal of Neuropsychopharmacology
96. Mechanistic Target of Rapamycin–Independent Antidepressant Effects of ( R )-Ketamine in a Social Defeat Stress Model
    Chun Yang, Qian Ren, Youge Qu, Ji‐chun Zhang, Min Ma, Chao Dong, Kenji Hashimoto · 2017 · Biological Psychiatry
97. Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine
    Fukumoto, Kenichi, Toki, Hidetoh, Iijima, Michihiko, Hashihayata, Takashi, Yamaguchi, Jun-ichi, Hashimoto, Kenji, Chaki, Shigeyuki · 2017 · The Journal of Pharmacology and Experimental Therapeutics
98. Sex differences in the antidepressant-like effects of ketamine
    Carrier, Nicole, Kabbaj, Mohamed · 2013 · Neuropharmacology
99. Cellular Plasticity Cascades in the Pathophysiology and Treatment of Bipolar Disorder
    Robert J. Schloesser, Jian Yuan Huang, Peter S. Klein, Husseini K. Manji · 2007 · Neuropsychopharmacology
100. Harmonizing the Neurobiology and Treatment of Obsessive-Compulsive Disorder
     Wayne K. Goodman, Eric A. Storch, Sameer Anil Sheth · 2021 · American Journal of Psychiatry